Zero2IPO logo

Zero2IPO

Asia, Beijing, China, Beijing

Description

Zero2IPO is an integrated service provider for the venture capital and private equity industry in China.

Investor Profile

Zero2IPO has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series C (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Zero2IPO frequently co-invest with?

GB
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Maison Capital
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1
SC
North America, New York, United States, New York
Co-Investments: 1
CDH Investments
Asia, Kowloon, Hong Kong, Kowloon City
Co-Investments: 1
Keyuan Industry Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
Oriza Holdings
Asia, Jiangsu, China, Suzhou
Co-Investments: 1
Dyee Capital
Asia, Fujian, China, Xiamen
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by Zero2IPO?

Elpiscience Biopharmaceuticals

Shanghai, Shanghai, China

Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies

BiopharmaBiotechnologyHealth CarePharmaceutical
Series CMay 13, 2021
Amount Raised: $105,000,000